Advertisement

Topics

FDA OKs new drug to treat all forms of hepatitis C

19:23 EDT 3 Aug 2017 | Topix

This photo provided by AbbVie shows the drug Mavyret. On Thursday, Aug. 3, 2017, the Food and Drug Administration approved Mavyret to treat all forms of hepatitis C. The drug works in as little as eight weeks and is for patients without significant cirrhosis who haven't been treated previously for the liver-destroying virus, plus patients who were not cured by a prior treatment.

Original Article: FDA OKs new drug to treat all forms of hepatitis C

NEXT ARTICLE

More From BioPortfolio on "FDA OKs new drug to treat all forms of hepatitis C"

Quick Search
Advertisement